Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients
Hydrogen has been shown to have antioxidant, anti-inflammatory, hormone-regulating, and apoptosis-resistance properties, among others. Based on a review of the research, the use of hydrogen might reduce the destructive cytokine storm and lung injury caused by SARS-CoV-2 during COVID-19 (Corona Virus...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2020-10-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.543718/full |
| id |
doaj-2f04f4bc902442dead71cf41fe6b62d6 |
|---|---|
| record_format |
Article |
| spelling |
doaj-2f04f4bc902442dead71cf41fe6b62d62020-11-25T04:01:38ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122020-10-011110.3389/fphar.2020.543718543718Hydrogen: A Potential New Adjuvant Therapy for COVID-19 PatientsFuxun YangRuiming YueXiaoxiu LuoRongan LiuXiaobo HuangHydrogen has been shown to have antioxidant, anti-inflammatory, hormone-regulating, and apoptosis-resistance properties, among others. Based on a review of the research, the use of hydrogen might reduce the destructive cytokine storm and lung injury caused by SARS-CoV-2 during COVID-19 (Corona Virus Disease 2019) in the early stage, stimulating ropy sputum drainage, and ultimately reducing the incidence of severe disease. Molecular hydrogen treatment has the potential to become a new adjuvant therapy for COVID-19, but its efficacy and safety require large clinical trials and further confirmation.https://www.frontiersin.org/article/10.3389/fphar.2020.543718/fullHydrogenCOVID-19therapycytokine stormmucus |
| collection |
DOAJ |
| language |
English |
| format |
Article |
| sources |
DOAJ |
| author |
Fuxun Yang Ruiming Yue Xiaoxiu Luo Rongan Liu Xiaobo Huang |
| spellingShingle |
Fuxun Yang Ruiming Yue Xiaoxiu Luo Rongan Liu Xiaobo Huang Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients Frontiers in Pharmacology Hydrogen COVID-19 therapy cytokine storm mucus |
| author_facet |
Fuxun Yang Ruiming Yue Xiaoxiu Luo Rongan Liu Xiaobo Huang |
| author_sort |
Fuxun Yang |
| title |
Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients |
| title_short |
Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients |
| title_full |
Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients |
| title_fullStr |
Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients |
| title_full_unstemmed |
Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients |
| title_sort |
hydrogen: a potential new adjuvant therapy for covid-19 patients |
| publisher |
Frontiers Media S.A. |
| series |
Frontiers in Pharmacology |
| issn |
1663-9812 |
| publishDate |
2020-10-01 |
| description |
Hydrogen has been shown to have antioxidant, anti-inflammatory, hormone-regulating, and apoptosis-resistance properties, among others. Based on a review of the research, the use of hydrogen might reduce the destructive cytokine storm and lung injury caused by SARS-CoV-2 during COVID-19 (Corona Virus Disease 2019) in the early stage, stimulating ropy sputum drainage, and ultimately reducing the incidence of severe disease. Molecular hydrogen treatment has the potential to become a new adjuvant therapy for COVID-19, but its efficacy and safety require large clinical trials and further confirmation. |
| topic |
Hydrogen COVID-19 therapy cytokine storm mucus |
| url |
https://www.frontiersin.org/article/10.3389/fphar.2020.543718/full |
| work_keys_str_mv |
AT fuxunyang hydrogenapotentialnewadjuvanttherapyforcovid19patients AT ruimingyue hydrogenapotentialnewadjuvanttherapyforcovid19patients AT xiaoxiuluo hydrogenapotentialnewadjuvanttherapyforcovid19patients AT ronganliu hydrogenapotentialnewadjuvanttherapyforcovid19patients AT xiaobohuang hydrogenapotentialnewadjuvanttherapyforcovid19patients |
| _version_ |
1724446052858200064 |